Spire Wealth Management’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History
Bought
Maintained
Sold
Other funds holding ZEAL
FCM
AIC
Spire Wealth Management's ZEAL Position: Q1 2022 in Review
Spire Wealth Management sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q1 2022, closing a stake of 300 shares — an estimated $6K sold.
Spire Wealth Management first reported a position in ZEAL in Q1 2021 and held it in 2 quarters. The position peaked at $10K in Q1 2021. 10 funds tracked by Wall St. Rank hold ZEAL as of Q1 2022.
- Spire Wealth Management reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q1 2022 after selling out during the quarter.
- Spire Wealth Management sold 300 Zealand Pharma A/S American Depositary Shares shares in Q1 2022, an estimated $6K.
- Spire Wealth Management first reported a position in Zealand Pharma A/S American Depositary Shares in Q1 2021 and held it in 2 quarters.
- Spire Wealth Management's Zealand Pharma A/S American Depositary Shares position peaked at $10K in Q1 2021.
- 10 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q1 2022.
Based on Spire Wealth Management's 13F filing for Q1 2022, filed 18 Apr 2022.